U.S. Sen. Maggie Hassan this week accused a national chain of opioid addiction clinics with multiple locations in New Hampshire of improper business practices that undermine the quality of care in pursuit of profit. In a letter to New Season obtained by the Bulletin, Hassan wrote that her team has conducted interviews with several employees […]
This change frees researchers to study cannabis products that most consumers encounter when buying medical marijuana – which could accelerate its treatment potential.
Doctronic reports non-drowsy allergy medications offer effective relief without sedation; popular options include loratadine, cetirizine, and fexofenadine.
GoodRx reports that seniors should use corticosteroid nasal sprays and avoid drowsy antihistamines like Benadryl to minimize side effects.
GoodRx reports many medications, like antidepressants and blood thinners, can cause hair loss.
A cannabis legalization movement that for a decade rode a wave of success has stalled amid failed ballot initiatives, rising health concerns and a frayed coalition of supporters.
Researchers are anxiously awaiting government action on rescheduling cannabis.
GoodRx reports that GLP-1 medications aid weight loss but often require long-term use to maintain results and prevent weight regain.
The thriving market in online, counterfeit GLP-1 drugs that do not meet FDA criteria poses serious risks to consumers.
Psilocybin falls into a regulatory gray zone, with strict limitations around how it can be studied. As a result, very little is known about its health risks, despite its surging popularity.